
AUAUniversity
The AUAUniversity podcast is an official podcast of the American Urological Association. It provides educational content for urologists and healthcare professionals. Episodes cover clinical updates, research, and best practices in urology. More information can be found at the AUAUniversity website.
Episodes
Update Series (2026) Lesson 18: Testosterone Therapy: Is It Safe? A Case-Based Approach
Update Series (2026) Lesson 18: Testosterone Therapy: Is It Safe? A Case-Based Approach
Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program a
AUA Guidelines: Advanced Prostate Cancer
AUA Guidelines: Advanced Prostate Cancer
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Kristen R. Scarpato, MD, MPH
To access the full guideline, please use the following link: https://www.auanet.org/guidelines-and-quality/guidelines/advanced-prostate-cancer
AUA2026: Focus on: Metastatic Urothelial Carcinoma (mUC)
AUA2026: Focus on: Metastatic Urothelial Carcinoma
CME Available: https://cme.auanet.org/URL/FOCUS264ONL
LEARNING OBJECTIVES:
After participating in this CME activity, participants will be able to:
1. Select appropriate first-line therapies for patients with locally advanced or metastatic urothelial carcinoma during initial treatment planning, in accordance with updated NCCN guidelines.
2. Evalu
AUA Guidelines: Clinically Localized Prostate Cancer
AUA Guidelines: Clinically Localized Prostate Cancer
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: James Eastham, MD, FACS
To access the full guideline, please use the following link: https://www.auanet.org/guidelines-and-quality/guidelines/clinically-localized-prostate-cancer
Update Series (2026): Kidney Stones and the Infected Patient
Update Series (2026): Kidney Stones and the Infected Patient
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Mantu Gupta, MD
Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and
AUA2026: Focus on: Biomarkers, MRI and PSMA PET Imaging in Prostate Cancer Webcast
AUA2026: Focus on: Biomarkers, MRI and PSMA PET Imaging in Prostate Cancer Webcast
CME Available: https://cme.auanet.org/URL/FOCUS262ONL
LEARNING OBJECTIVES:
After participating in this CME activity, participants will be able to:
1. Critically appraise recent developments in imaging biomarkers and molecular diagnostics (e.g., genomic risk scores, liquid biopsy) and discuss how they complement MR
AUA2026 Spotlight: PARP-Inhibitor Combination Treatments for the Urologic Care Team
AUA2026 Spotlight: PARP-Inhibitor Combination Treatments for the Urologic Care Team
CME Available: https://cme.auanet.org/URL/PARP26ONL
LEARNING OBJECTIVES:
At the conclusion of this CME activity, participants will be able to:
1. Integrate biomarker and genetic testing principles into clinical workflows for patients with metastatic prostate cancer, including when to order testing, how to interpr
Update Series (2026) Lesson 15: Case-Based Testicular Cancer Clinical Practice Guidelines
Update Series (2026) Lesson 15: Case-Based Testicular Cancer Clinical Practice Guidelines
Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program
AUA Guidelines: Management of Lower Urinary Tract Symptoms Attributed to BPH
AUA Guidelines: Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Jaspreet S. Sandhu, MD
To access the full guideline, please use the following link: https://www.auanet.org/guidelines-and-quality/guidelines/bph-guideline.
Please note that access to the full guideline requires user login. If you do not already have a
AUA2026: Society of Women in Urology Meeting
AUA2026: Society of Women in Urology Meeting
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Amy N. Luckenbaugh, MD, FACS
To register for AUA2026, please visit auanet.org/AUA2026/register!
AUA2026: Society of Urologic Oncology Meeting
AUA2026: Society of Urologic Oncology Meeting
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Dr. Kelvin A. Moses, MD, PhD & Dr. Mark A. Preston, MD, MPH
To register for AUA2026, please visit auanet.org/AUA2026/register!
AUA2026: Society of Benign Prostate Disease Meeting
AUA2026: Society of Benign Prostate Disease Meeting
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Kevin Thomas McVary, MD, FACS
To register for AUA2026, please visit auanet.org/AUA2026/register!
AUA Guidelines: Early Detection of Prostate Cancer
AUA Guidelines: Early Detection of Prostate Cancer
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Simpa Salami, MD, MPH
Lin DW, Carlsson S, Filson CP, et al. Updates to Early Detection of Prostate Cancer: AUA/SUO Guideline (2026).J Urol. 0(0).10.1097/JU.0000000000004995. https://www.auajournals.org/doi/10.1097/JU.0000000000004995
AUA2026: Sexual Medicine Society of North America Meeting
AUA2026: Sexual Medicine Society of North America Meeting
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Landon Trost, MD,
To register for AUA2026, please visit auanet.org/AUA2026/register!
AUA2026: Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) Meeting
AUA2026: Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) Meeting
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Anne Pelletier Cameron, MD, URPS
To register for AUA2026, please visit auanet.org/AUA2026/register!
Update Series (2026): At-Home Diagnostic and Therapeutic Options in Men's Health
Update Series (2026): At-Home Diagnostic and Therapeutic Options in Men's Health
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Richard J. Fantus, MD
Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series
AUA2026: Research Programming Preview: Amplifying the Impact of Research for Career Development
AUA2026: Research Programming Preview: Amplifying the Impact of Research for Career Development
Host: H. Henry Lai, MD
Guest: Naveen Kachroo, MD, PhD
Joining us today for this special episode brought to you by the AUA Office of Research, Research Education Committee, are Drs. H. Henry Lai and Naveen Kachroo discussing the dynamic research education programming planned at AUA2026. Head to auanet.
Update Series (2026): Perioperative Management of Urinary Diversion
Update Series (2026): Perioperative Management of Urinary Diversion: What Every Urologist Should Know
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Rohit Reddy, MD
Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the A
AUA2026: Advanced Cystoscopy Training for APPs
AUA2026: Advanced Cystoscopy Training for APPs
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guests: Brett Johnson, MD and Davis Viprakasit, MD, FACS
Tune in to hear straight from the experts about our newest Hands-On Skills Training offering - Advanced Cystoscopy Training for APPs, part of the pre-meeting programming at AUA2026! In this episode, Dr. Brett Johnson and Dr. Davis Viprakasit discuss all abo
LG-IR-NMIBC Treatment Landscape (Republished)
LG-IR-NMIBC Treatment Landscape (Republished)
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Chad R. Ritch, MD, MBA, FACS
CME Available: cme.auanet.org/URL/GUPOD251
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
AstraZeneca
Johnson & Johnson
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Differentiate between traditional and e
NMIBC Treatment Landscape (Republished)
NMIBC Treatment Landscape (Republished)
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Janet Kukreja, MD, MPH, FACS
CME Available: https://cme.auanet.org/URL/GUPOD253
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
AstraZeneca
Johnson & Johnson
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Select and implement immunotherapy re
MIBC Treatment Landscape (Republished)
MIBC Treatment Landscape (Republished)
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Jen-Jane Liu, MD, FACS
CME Available: https://cme.auanet.org/URL/GUPOD252
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
AstraZeneca
Johnson & Johnson
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Integrate immunotherapy and targeted therapy
AUA2025: Key Takeaways: Bladder Cancer
AUA2025: Key Takeaways: Bladder Cancer
Presenters: Patrick Hensley, MD & Janet Kukreja, MD
Update Series (2026) Lesson 5: Long-term Urinary Catheters: Their Role & Management of Complications
Update Series (2026) Lesson 5: Long-term Urinary Catheters: Their Role & Management of Complications
Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-st
Adjuvant Therapy for Renal Cell Carcinoma
Adjuvant Therapy for Renal Cell Carcinoma
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Daniel Shapiro, MD, FACS
CME Available:
https://cme.auanet.org/URL/RCCPOD261
ACKNOWLEDGEMENTS:
Support provided by an independent educational grant from:
Merck & Co., Inc.
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Define adjuvant therapy, review current clinical
Use of Suction Ureteroscopes for Kidney Stone Treatment: CVAC System
Use of Suction Ureteroscopes for Kidney Stone Treatment: CVAC System
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Karen L. Stern, MD
Update Series: The Role of Nephrectomy in Advanced Kidney Cancer
Update Series: The Role of Nephrectomy in Advanced Kidney Cancer
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Sarah P. Psutka, M.D., M.S., F.A.C.S.
Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Serie
AI for Prostate Cancer Treatment Planning
AI for Prostate Cancer Treatment Planning
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Wayne G. Brisbane, MD
AUA Guidelines: Salvage Therapy for Prostate Cancer
AUA Guidelines: Salvage Therapy for Prostate Cancer
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Yaw Nyame, MD, MS, MBA
Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part I: introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy. J Urol. 2024;211(4):509-517. https://www.a
AUA Guidelines: Diagnosis and Management of Male Chronic Pelvic Pain
AUA Guidelines: Diagnosis and Management of Male Chronic Pelvic Pain
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guests: Elise JB De, MD & Dane Johnson, MD
Lai HH, Pontari MA, Argoff CE, et al. Male Chronic Pelvic Pain: AUA Guideline: Part I Evaluation and Management Approach. J Urol. 0(0). doi:10.1097/JU.0000000000004564. https://www.auajournals.org/doi/10.1097/JU.0000000000004564
Lai HH, Pontari MA
NMIBC Treatment Landscape
NMIBC Treatment Landscape
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Janet Kukreja, MD, MPH, FACS
CME Available: https://cme.auanet.org/URL/GUPOD253
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
AstraZeneca
Johnson & Johnson
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Select and implement immunotherapy regimens for pa
MIBC Treatment Landscape
MIBC Treatment Landscape
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Jen-Jane Liu, MD, FACS
CME Available: auau.auanet.org/node/44077
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
AstraZeneca
Johnson & Johnson
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Integrate immunotherapy and targeted therapy into the multimodal ma
AUA Guidelines: Genitourinary Syndrome of Menopause
AUA Guidelines: Genitourinary Syndrome of Menopause
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guests: Tracey S. Wilson, MD & Una J. Lee, MD
Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline (2025)
Kaufman MR, Ackerman LA, Amin KA, et al. The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. J Urol. 0(0). doi:10.1097/JU.0000000000004589. https://www.auajournals.org/doi/10.109
LG-IR-NMIBC Treatment Landscape
LG-IR-NMIBC Treatment Landscape
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Chad R. Ritch, MD, MBA, FACS
CME Available: https://cme.auanet.org/URL/GUPOD251
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
AstraZeneca
Johnson & Johnson
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Differentiate between traditional and emerg
Core Curriculum: Surgical Management of Urolithiasis
Core Curriculum: Surgical Management of Urolithiasis
AUA Urology Core Curriculum: auau.auanet.org/core
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guests: Marcelino E. Rivera, MD and T. Max Shelton, MD
Outline:
Segment 1: Acute Stone Event and Radiographic Evaluation
Segment 2: Shock Wave Lithotripsy
Segment 3: Ureteroscopy
Segment 4: Percutaneous Nephrolithotomy
Segment 5: Intracorporeal Lithotripsy
AUA2025: Key Takeaways: BPH
AUA2025: Key Takeaways: BPH
Presenters: Bilal Chughtai, MD & Dean S. Elterman, MD, MSc, FRCSC
AUA2025: Key Takeaways: Lower Urinary Tract Reconstruction
AUA2025: Key Takeaways: Lower Urinary Tract Reconstruction
Presenters: George E. Koch, MD & Kurt A. McCammon, MD, FACS
AUA Guidelines: Recurrent Uncomplicated Urinary Tract Infections in Women
AUA Guidelines: Recurrent Uncomplicated Urinary Tract Infections in Women
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guests: A. Lenore Ackerman, MD, PhD & Melissa R. Kaufman, MD, PhD
Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2025)
Ackerman AL, Bradley M, D’Anci KE, Hickling D, Kim SK, Kirkby E. Updates to Recurrent Uncomplicated Urinary Tract Infections in Wome
Core Curriculum: Anorectal Malformation
Anorectal Malformation
AUA Urology Core Curriculum: auau.auanet.org/core
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guests: Christina Ho, MD and Molly E. Fuchs, MD
Outline:
Segment 1: Anorectal Malformation Overview/Background
Segment 2: Initial Evaluation and Management
Segment 3: Cloacal Malformations
Segment 4: Long-Term Bladder Management & Concern for CKD
Segment 5: Other Considerations
AUA2025: Key Takeaways: Endourology/Stones Highlights
AUA2025: Key Takeaways: Endourology/Stones Highlights
Presenters: Davis Viprakasit, MD & Stephen Nakada MD, FACS, FRCS
Update Series (2025) Lesson 30: Beyond Ureteropelvic Junction: Case-Based Tips and Tricks in Robotic Ureteral Stricture Reconstructive Surgery
Update Series (2025) Lesson 30: Beyond Ureteropelvic Junction: Case-Based Tips and Tricks in Robotic Ureteral Stricture Reconstructive Surgery
Now in its 44th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the
The Latest Breakthroughs in LG-IR-NMIBC (2025)
The Latest Breakthroughs in LG-IR-NMIBC (2025)
CME Available: auau.auanet.org/node/43689
After participating in this CME activity, participants will be able to:
1. Apply updated clinical evidence and treatment protocols for low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC) in appropriate patient cases to reduce recurrence rates and improve clinical outcomes.
2. Improve cli
The Latest Breakthroughs in mHSPC
The Latest Breakthroughs in mHSPC
CME Available: https://auau.auanet.org/node/43825
After participating in this CME activity, participants will be able to:
1.Evaluate the concept of personalized therapy and its importance in the treatment of de novo mHSPC.
2.Implement current clinical guidelines for biomarker testing in mHSPC.
3.Explain the role of the PI3K/AKT pathway in prostate cancer biology
AUA2025: Key Takeaways: Sexual Dysfunction Highlights
AUA2025: Key Takeaways: Sexual Dysfunction Highlights
Presenter: Brittany Berk, MD & Arthur Burnett, MD, MBA
AUA2025: Key Takeaways: Female Urology Highlights
AUA2025: Key Takeaways: Female Urology Highlights
Presenter: Mitch G. Goldenberg, MD & Kathleen Kobashi, MD, MBA, FACS
AUA2025: John Duckett Memorial Lecture: Obstructive Bladder Disease: Molecular Insights and Therapeutic Opportunities
AUA2025: John Duckett Memorial Lecture: Obstructive Bladder Disease: Molecular Insights and Therapeutic Opportunities
Presenter: Rosalyn M. Adam, PhD
AUA2025: Ramon Guiteras Lecture: The Future of Healthcare: How Will Urology be Impacted?
AUA2025: Ramon Guiteras Lecture: The Future of Healthcare: How Will Urology be Impacted?
Presenter: Vin Gupta, MD, MPA
AUA2025: John K Lattimer Lecture: Telesurgery
AUA2025: John K Lattimer Lecture: Telesurgery
Presenter: Vipul Patel, MD
Contemporary Management of MIBC and Beyond: Expert Guidance for Urologists (Republished)
Contemporary Management of MIBC and Beyond: Expert Guidance for Urologists (Republished)
CME Available: auau.auanet.org/node/42040
After participating in this CME activity, participants will be able to:
1. Describe the multimodal treatment approach for MIBC, including surgery, radiation therapy, and chemotherapy.
2. Analyze the role of neoadjuvant and adjuvant therapies, including chemotherapy,
AUA2025: Chemotherapy and Immunotherapy for Urologists and Advanced Practice Providers (APPs)
AUA2025: Chemotherapy and Immunotherapy for Urologists and Advanced Practice Providers (APPs)
CME Available: https://auau.auanet.org/node/43009
At the conclusion of this activity, participants will be able to:
1. Identify the guidelines for first-line and beyond treatment of patients with hormone-sensitive advanced and metastatic prostate cancer, including medications, their mechanism, side eff
Update Series (2025) Lesson 18: Multidisciplinary Evaluation and Management of Pelvic Pain in Women
Update Series (2025) Lesson 18: Multidisciplinary Evaluation and Management of Pelvic Pain in Women
Now in its 44th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-stu
AUA2025: Incorporating Genomic Testing and Advanced Imaging for Prostate Cancer Into Your Practice
AUA2025: Incorporating Genomic Testing and Advanced Imaging for Prostate Cancer Into Your Practice
CME Available: https://auau.auanet.org/node/43029
At the conclusion of this activity, participants will be able to:
1. Describe the research that led to the approval of genomic testing for prostate cancer and the implementation of advanced imaging for prostate cancer
2. Order appropriate genomic te
AUA2025: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems
AUA2025: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems
CME Available: https://auau.auanet.org/node/43047
At the conclusion of this activity, participants will be able to:
1. Implement current practice guidelines and explain methods and resources to improve transurethral resection of a bladder tumor (TURBT) skills.
2. Identify the best intravesical age
The Surgical Management of BPH (2025)
The Surgical Management of BPH (2025)
CME Available: https://auau.auanet.org/node/43193
Acknowledgements: This educational series is supported by an independent educational grant from Olympus Corporation of the Americas.
After participating in this CME activity, participants will be able to:
1. Utilize the AUA Clinical Guideline on the Management of Lower Urinary Tract Symptoms Attributed to Ben
AUA2025: AUA Advanced Prostate Cancer Course
AUA2025: AUA Advanced Prostate Cancer Course
CME Available: https://auau.auanet.org/node/43035
At the conclusion of this activity, participants will be able to:
1. Describe appropriate use of genetic testing (germline) and understand the importance of genetic counseling.
2. Describe appropriate use of somatic testing and treatments related to specific genetic alterations.
3. Identify appropriate
AUA2025: Should I Order a PET Scan? Integrating Molecular Imaging Into Urologic Oncology Clinical Practice: Current Approaches and Future Opportunities
AUA2025: Should I Order a PET Scan? Integrating Molecular Imaging Into Urologic Oncology Clinical Practice: Current Approaches and Future Opportunities
CME Available: https://auau.auanet.org/node/43003
At the conclusion of this activity, participants will be able to:
1. Analyze the best available evidence on the current diagnostic imaging options for prostate, kidney, bladder, and testis cancer
AUA2025: AUA Guidelines on Early Detection of Prostate Cancer: Maximizing Benefits, Minimizing Harm
AUA2025: AUA Guidelines on Early Detection of Prostate Cancer: Maximizing Benefits, Minimizing Harm
CME Available: https://auau.auanet.org/node/43021
At the conclusion of this activity, participants will be able to:
1. Apply the Early Detection of Prostate Cancer: AUA/SUO Guideline (2023), and understand the rationale, evidence, level of evidence, strength of recommendation and applications asso
AUA2025: Genetics and Genomics of Urological Cancers - Current Guidelines and Case-based Discussion to Guide Clinical Practice
AUA2025: Genetics and Genomics of Urological Cancers - Current Guidelines and Case-based Discussion to Guide Clinical Practice
CME Available: https://auau.auanet.org/node/43015
At the conclusion of this activity, participants will be able to:
1. Describe key components of genetic risk assessment, genetic counseling, and informed consent for genetic testing.
2. Describe elements of genetic test
Highlights from AUA2025: Advances in NMIBC (2025)
Highlights from AUA2025: Advances in NMIBC (2025)
CME Available: https://auau.auanet.org/node/43167
At the conclusion of this CME activity, participants will be able to:
1. Recognize recent developments in the management of NMIBC.
2. Evaluate new and emerging therapies for NMIBC, such as novel intravesical agents and immunotherapies, their mechanism of action and related adverse events.
3.
AUA Guidelines: Microhematuria
AUA Guidelines: Microhematuria
Co-Hosts: Daniel A. Barocas, MD, MPH & Stephen Boorjian, MD
Microhematuria: AUA/SUFU Guideline (2025)
Barocas DA, Lotan Y, Matulewicz RS, Raman JD, Westerman ME, Kirkby E, Pak L, Souter L. Updates to Microhematuria: AUA/SUFU Guideline (2025). J Urol. 0(0). doi: 10.1097/JU.0000000000004490. https://www.auajournals.org/doi/abs/10.1097/JU.0000000000004490
AUA2025: Embracing Multi-Disciplinary Care for Advanced Prostate Cancer: A Case-Based Update 2025
AUA2025: Embracing Multi-Disciplinary Care for Advanced Prostate Cancer: A Case-Based Update 2025
CME Available: https://auau.auanet.org/node/42997
At the conclusion of this activity, participants will be able to:
1. Initial Management of Metastatic Prostate Cancer: Evaluate and treat a patient with new diagnosed M1 prostate cancer with androgen deprivation therapy (ADT) plus be skilled to off
AUA2025: Non-Muscle Invasive Bladder Cancer Treatment Dilemmas: The Cases You Face and How Best to Treat Them
AUA2025: Non-Muscle Invasive Bladder Cancer Treatment Dilemmas: The Cases You Face and How Best to Treat Them
CME Available: https://auau.auanet.org/node/43041
At the conclusion of this activity, participants will be able to:
1. Confidently apply updated guidelines to the care of patients with non-muscle-invasive bladder cancer.
2. Risk-stratify patients with non muscle- invasive bladder cancer.
AUA2025: Integration of Biomarkers, MRI and PSMA PET Imaging Into the Management of Prostate Cancer
AUA2025: Integration of Biomarkers, MRI and PSMA PET Imaging Into the Management of Prostate Cancer
CME Available: https://auau.auanet.org/node/43069
At the conclusion of this CME activity, participants will be able to:
1. Evaluate recent advances in biomarkers and molecular imaging technologies and their role in improving the accuracy of prostate cancer staging, and treatment monitoring.
2. Ide
AUA2025: PARP-Inhibitor Combination Treatments for the Urologic Care Team
AUA2025: PARP-Inhibitor Combination Treatments for the Urologic Care Team
CME Available: https://auau.auanet.org/node/42822
At the conclusion of this CME activity, participants will be able to:
1. Apply the mechanism of action of PARP inhibitors and the rationale for using them in patients with advanced prostate cancer.
2. Recognize the role and importance of genetic testing in patients with mCR
Live from AUA2025: Advances in ADT Program
Live from AUA2025: Advances in ADT Program
CME Available: https://auau.auanet.org/content/LiveFromAUA2025#group-tabs-node-course-default1
ACKNOWLEDGEMENTS:
This educational activity is supported by independent educational grants from:
Pfizer, Inc.
Sumitomo Pharma America, Inc.
At the conclusion of this CME activity, participants will be able to:
1. Employ the latest AUA and NCCN guidelines (
AUA2025: Sexual Medicine Society of North America Meeting
AUA2025: Sexual Medicine Society of North America Meeting
Cohost: Landon Trost, MD
Outline:
Segment #1: What is the Sexual Medicine Society of North America and what unique value does it bring to its members and the broader field of urology.
Segment #2: For the AUA2025 meeting, what can you tell us about the agenda and what the audience can expect from the meeting?
Segment #3: What are the mai
AUA2025: Society of Urological Robotic Surgeons Meeting
AUA2025: Society of Urological Robotic Surgeons Meeting
Cohost: Michael D. Stifelman, MD
Outline:
Segment #1: What is the Society of Urological Robotic Surgeons and what unique value does it bring to its members and the broader field of urology.
Segment #2: For the AUA2025 meeting, what can you tell us about the agenda and what the audience can expect from the meeting?
Segment #3: What are the
AUA2025: Focal Therapy Society Meeting
AUA2025: Focal Therapy Society Meeting
Cohost: Rafael Sanchez-Salas, MD
Outline:
Segment #1: What is the Focal Therapy Society and what unique value does it bring to its members and the broader field of urology.
Segment #2: For the AUA2025 meeting, what can you tell us about the agenda and what the audience can expect from the meeting?
Segment #3: What are the main clinical areas being highlig
Update Series 2025: Congenitalism: Transitioning Patients with Congenital Urological Anomalies
Update Series 2025 Lesson 9: Congenitalism: Transitioning Patients with Congenital Urological Anomalies from the Pediatric to the Adult Care Setting
Update Series 2025 Lesson 9: Congenitalism: Transitioning Patients with Congenital Urological Anomalies from the Pediatric to the Adult Care Setting
Now in its 44th installment, the AUA Update Series is renowned for delivering high-quality lessons t
AUA2025: Masterclass: Renal Access and Interventions (2025)
AUA2025: Masterclass: Renal Access and Interventions (2025)
Cohost: Rob Sweet, MD, FACS, MAMSE and Thomas Chi, MD, MBA
Tune in to hear straight from the experts about what you can expect from our NEWLY DESIGNED Full Day Hands-on Skills Trainings at AUA2025! In this episode, Drs. Thomas Chi and Robert Sweet discuss Masterclass: Renal Access and Interventions, an all new interactive training offer
Hereditary Kidney Cancer Syndromes (Republished)
Hereditary Kidney Cancer Syndromes
CME Available: https://auau.auanet.org/node/41772
ACKNOWLEDGEMENTS:
Support provided by an independent educational grant from:
Merck & Co., Inc.
LEARNING OBJECTIVES:
At the conclusion of this activity, participants should be able to:
1. Select patients who should undergo genetic testing to identify hereditary kidney cancer syndromes based on appropriate crit
AUA2025: Fundamentals of Prostate MRI and Transperineal Interventions (2025)
AUA2025: Fundamentals of Prostate MRI and Transperineal Interventions (2025)
Cohost: Arvin K. George, MD and James Wysock, MD, MSc
Tune in to hear straight from the experts about what you can expect from our NEWLY DESIGNED Full Day Hands-on Skills Trainings at AUA2025! In this episode, Dr. Arvin K. George and Dr. James Wysock discuss optimizing diagnosis of clinically significant prostate cancer
Recognition and Management of Complications Following Gender Affirming Surgery
Recognition and Management of Complications Following Gender Affirming Surgery
Co-Host: Laura Douglass, MD
Outline:
Segment #1 Topic: Why is this important for ALL urologists to know?
Segment #2 Topic: Introduction to Gender Affirming Surgery (GAS)
Segment #3 Topic: Emergency/ED consultations vs. Outpatient/clinic consultations
Resources:
- Hanley K, Wittenberg H, Gurjala D, Safir MH, Chen E
AUA Guidelines: Diagnosis and Treatment of Infertility in Men
AUA Guidelines: Diagnosis and Treatment of Infertility in Men
Co-Host: Robert E. Brannigan, MD
Outline:
Segment #1 Topic: New Table 1 Reviewing “Common Terms” in Semen Analysis and Update to the WHO Semen Analysis Reference Ranges
Segment #2 Update to the WHO Semen Analysis Reference Ranges
Segment #3 Topic: Y Chromosome Microdeletion Testing Change in Testing Guidance
Segment #4 Topic: Pelvic M
AUA Guidelines: Diagnosis And Treatment Of Idiopathic Overactive Bladder
AUA Guidelines: Diagnosis And Treatment Of Idiopathic Overactive Bladder
Co-Host: Anne Pelletier Cameron, MD, FRCSC, URPS
Segment #1: Is this an update to the prior Guideline?
Segment #2: What is new in the Diagnosis, ntitial Assessment and Initial Management of OAB?
Segment#3: What does the Guideline say about Oral Medication?
Segment #4: What's new in minimally invasive prodcedures
Segment
AUA Guidelines: Treatment Of Non - Metastatic Muscle - Invasive Bladder Cancer
AUA Guidelines: Treatment Of Non - Metastatic Muscle - Invasive Bladder Cancer
Guest: Jeffrey M Holzbeierlein, MD
Outline:
Segment #1: Guideline Statement 9-Patients who have not received cisplatin-based NAC and have pT3-4 and/or N= disease at cystectomy should receive adjuvant cisplatin based chemotherapy or adjuvant immunotherapy.
Segment #2: Guideline Statement 11-When performing a cystecto
Biomarkers and Molecular Imaging for Prostate Cancer (Republished)
Biomarkers and Molecular Imaging for Prostate Cancer
CME Available: auau.auanet.org/node/41727
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
Lantheus Medical Imaging
Novartis Pharmaceuticals Corporation
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Explain the principles of molecular imaging and its application in prostat
Appropriate Use of Genetic Testing (Republished)
Appropriate Use of Genetic Testing (who, what, when and how?)
CME Available: auau.auanet.org/node/41734
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
Lantheus Medical Imaging
Novartis Pharmaceuticals Corporation
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Identify the patient populations that should be considered for ge
Treatment Intensification in Metastatic HSPC (Republished)
Treatment Intensification in Metastatic HSPC
CME Available: https://auau.auanet.org/node/41733
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
Lantheus Medical Imaging
Novartis Pharmaceuticals Corporation
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Explain the rationale behind treatment intensification in metastatic hormo
Sequencing Of Agents (Republished)
Sequencing Of Agents
CME Available: auau.auanet.org/node/41735
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
Lantheus Medical Imaging
Novartis Pharmaceuticals Corporation
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Review the latest evidence and clinical guidelines that inform the sequencing of therapeutic agents in meta
Recommended

Doug Spence | Unlocking Potential Podcast

Power List

Problematic Pub Podcast

Athens, GA Real Estate Brief

Changing Academic Life

The Trail Went Cold

Breaking the Cycle

Bloom and Belong

Bruno Mars - Biography Flash

Spiritual Wisdom Weekly – from GOCSL

Self Love Chats: Money Mindset & Personal Growth for Ambitious Women

Dad V Girls After Hours